Archive · 19 Jun 2025
Pharma Firms in Focus: Distribution Deals and FDA Observations
Several pharmaceutical companies are in the news.
Abbott will now distribute diabetes medicines in India, thanks to a deal with MSD Pharmaceuticals.
The FDA has given Zydus some feedback about their cancer drug plant.
Welcure Drugs & Pharmaceuticals will get help sourcing and buying medicine from a company in Thailand.
Abbott and MSD Pharmaceuticals partnered to distribute diabetes medicines in India.
The partnership involves sitagliptin and related medications.
Zydus received two observations from the FDA regarding its oncology plant.
The observations followed a GMP follow-up inspection.
Welcure Drugs & Pharmaceuticals signed a sourcing mandate with Fortune Sagar Impex.
- Who
- Abbott, MSD Pharmaceuticals, Zydus, and Welcure Drugs & Pharmaceuticals.
- What
- Multiple pharmaceutical companies announced developments.
- When
- Announcements made around June 19, 2025.
- Where
- India, Ahmedabad, and Thailand.
- Why
- These announcements are related to business operations and regulatory compliance.
- Companies Involved
- Abbott, MSD, Zydus, Welcure
- Drug Type
- Anti-diabetic and Oncology
- FDA Observations
- Issued to Zydus's oncology plant
- Partnership Purpose
- Distribution and Sourcing
- Welcure's Contract
- ₹517 crore sourcing and procurement services